What you need to know about dementia.
Searching for Solutions
What you need to know about vaccinations.
What you need to know about alcohol use disorder.
What you need to know about catatonia.
What you need to know about the end of medication treatment.
Many individuals with hepatic impairment are impacted by psychiatric disorders. Co-occurring substance use disorders are also prevalent and have been associated with increased risk of liver disease. Though limited, literature exists to support safe medication prescribing in patients with hepatic dysfunction, including those with cirrhosis.
Tanya J. Fabian, PharmD, PhD, BCPP Director, Pharmacy Research and Pharmacy Services Director, PGY2 Psychiatric Pharmacy Residency UPMC Western Psychiatric Hospital Associate Professor of Pharmacy & Therapeutics and Psychiatry University of Pittsburgh Schools of Pharmacy and Medicine
The MSL Perspective Brittany Finocchio, PharmD, BCPP Medical Science Liaison Karuna Therapeutics Inc The Woodlands, TX
Ashley Maister, BS, PharmD, BCPP Clinical Pharmacy Practitioner, Psychiatry Corporal Michael J. Crescenz Veterans Affairs Medical Center Philadelphia, Pennsylvania
Carolanne Wartman, PharmD, BCPS, BCPP (she/her) Clinical Assistant Professor of Pharmacy Practice The University of Mississippi School of Pharmacy Jackson, MS
Kaitlyn Q. Weslosky, PharmD, BCPP Clinical Pharmacy Provider- Psychiatry Robert J. Dole VA Medical Center Wichita, KS
What you need to know about Stimulant Use Disorder Treatment.
Julie Thiel, BS Pharm, PharmD State of Wisconsin Department of Health Services, Division of Public Health, Bureau of Community Health Promotion, Family Health Section, Children and Youth with Special Health Care Needs Unit Supervisor Madison, WI
What you need to know about Nonpharmacological/Alternative Treatment Options.
What you need to know about Antipsychotic Induced Weight Gain.
What you need to know about Psychedelic Therapies: Safety and Legality of Psychedelic Compounds.
What you need to know about Accessing Mental Health Treatment.
What you need to know about Harm Reduction for People Who Use Drugs (PWUD).
American Academy of Neurology Practice parameter: Antiepileptic drug prophylaxis in severe traumatic brain injury | Neurology American College of Emergency Physicians (ACEP)
American Academy of Neurology (AAN) Oral and topical treatment of painful diabetic polyneuropathy practice guidelines (2021) American Diabetes Association
Amyotrophic Lateral Sclerosis (ALS) ALS Canada Canadian best practice recommendations for the management of amyotrophic lateral sclerosis (2020) American Academy of Neurology (AAN)
American Headache Society (AHS)
Many patients and providers can be hesitant to utilize medications during pregnancy due to concerns of harm to the fetus. However, medications in pregnancy cannot always be avoided, especially in patients where the benefit outweighs the risks. Exacerbations of mental health conditions can increase risks for both mother and fetus. For each medication and each individual pregnancy, the risks and benefits must be carefully weighed.
What you need to know about Tardive Dyskinesia (TD).
Dr. Katie Tuck (Chamberlain), PharmD, BCPP, BCPS Assistant Professor of Pharmacy Practice – Psychiatry Regis University School of Pharmacy Denver, CO